Tunisia medical device regulations
Official sources linkedAgence Nationale du Médicament et des Produits de Santé (ANMPS) rules and guidance for medical device market access, registration, and lifecycle compliance. Each code opens a metadata page with the official source and readable HTML when available.
| Code | Regulation | Category | Effective | Provenance |
|---|---|---|---|---|
| P-OP2-001-FR, Rev 000 | Contrôle des dispositifs médicaux, des compléments alimentaires, des produits cosmétiques et des objets de puériculture dans le cadre du contrôle technique à l'importation P-OP2-001-FR, revision 000 of 5 June 2025, by the ANMPS — the procedure for the technical control at importation of medical devices, food supplements, cosmetic products and childcare articles. Two numbered sections: section 1 presents the document (object, entry into force, references, responsibilities and distribution) and section 2 describes the control, separating cosmetics and food supplements (2.1) from medical devices and childcare articles (2.2), and within the device route separating what is subject only to a technical opinion (2.2.1) from what is subject to a systematic analysis (2.2.2), followed by the conditions for applying the procedure (2.3) and the conditions for obtaining an administrative import authorisation (2.4). A 'Pièce Jointe' block carries the attachment the procedure refers to. This is the instrument that decides what happens to a device consignment at the Tunisian border, and it is the counterpart to the customs-side rules the ANMPS note on hyaluronic-acid devices also touches. | Registration | — | Official |
| T-OP9-003-FR, V : 000 | Guide d'élaboration d'un dossier technique de dispositifs médicaux T-OP9-003-FR, version 000, issued 26 February 2026 and applicable from 2 March 2026, by the ANMPS — the guide to building the technical file for a medical device. Two numbered sections under the Agency's standard cover: section 1 presents the document (its object, scope, entry into force, references and the responsibilities it allocates), and section 2 is the substance — the documents required for device control, first in the technical-opinion route (2.1) and then in the device-analysis route (2.2). It ends with the version history and the validation block, which name the document's writers and approvers. The extract follows the document's own contents page, so the section ids are the document's own numbers, and its version history table (version 000, création, application 02/03/2026) is carried as its own block. | Registration | — | Official |
| F-MG1-002-FR, Rev 000 | Note d'information à l'attention des importateurs — révision du statut des dispositifs médicaux à base d'acide hyaluronique F-MG1-002-FR, revision 000 — an information note addressed to importers, announcing that following the revision of the status of medical devices based on hyaluronic acid, Tunisian customs has reclassified them under tariff heading 30049000 of the customs nomenclature, in chapter 30 of the tariff. The consequence the note states is that importing these products is now subject to the State monopoly, and that a derogation from the State monopoly (document code 120) must first be obtained from the Ministry of Health through the ANMPS; the note adds that the derogation is valid for twelve months from 25 August 2025. It is a tariff and import-route notice rather than a device-approval rule, and it is the reason a hyaluronic-acid filler importer cannot treat the product as an ordinary registered device. The note's own letterhead date field reads "Date 16/05/2025" while the letter itself is dated "Tunis, le 03/10/2025"; the letter date is recorded here, because the note's own content — a twelve-month derogation running from 25 August 2025 — cannot predate it, and both dates are visible in the extract. | General | — | Official |
Changes after registration in Tunisia
Source-linked rules for common changes to a registered medical device. Read the scope and conditions with each rule; unverified details are listed separately.
Does changing a device brand name or logo require an update?
A change to the registered brand name and a change to logo artwork can follow different rules. The legal manufacturer, device design and intended purpose remain the same.
A source-verified answer for this specific scenario is not yet published.
How do I update a manufacturer's name without changing the legal entity?
The same legal manufacturer changes its name, potentially alongside the device brand. A transfer to another legal entity is a separate question; permission to combine filings needs its own evidence.
A source-verified answer for this specific scenario is not yet published.
What changes when the manufacturer's office address changes?
An office address change for the same legal entity, potentially alongside name and brand changes. This does not cover moving a factory or manufacturing site, and a combined filing cannot be assumed.
A source-verified answer for this specific scenario is not yet published.
Does a catalogue or reference code change affect registration or UDI?
Check which identifier actually changes. A commercial catalogue, REF or order code is not automatically a device model, registered identifier, GTIN or UDI-DI. Rules for one identifier do not establish the route for another.
A source-verified answer for this specific scenario is not yet published.
Can a registration transfer to a different legal entity?
A real change of legal manufacturer, registration holder or owner. This differs from renaming the same entity; a change of local representative or importer alone does not establish a registration transfer route. Where other changes occur with the transfer, the exact combination and sequence need separate evidence.
A source-verified answer for this specific scenario is not yet published.
Can several changes be filed together?
Changes to brand, manufacturer name, office address and reference codes may occur together, including with a real transfer to another legal manufacturer, registration holder or owner. Assess transfer with each single change, and transfer with brand plus reference, manufacturer name plus reference, or office address plus reference changes: seven transfer combinations in total. Evidence must establish the exact combination and the order of filings and approvals. These combinations and their sequence are not all verified by the rules below; a rule for one change does not prove that a single application, fee or review period covers the combination.
A source-verified answer for this specific scenario is not yet published.
What these codes are
Each row above represents one regulatory instrument. Its code is the authority’s identifier. A regulation page collects the metadata and official source; when readable HTML is available, article links can open and highlight the exact cited passage.
Continue from regulations into practical research
Keep Tunisia as the target market while you move into registration records, classification, cross-country product research, or pathway planning.
Classify a device for Tunisia
Check a preliminary Agence Nationale du Médicament et des Produits de Santé (ANMPS) risk class.
Compare products across markets
Search the same product in multiple country registries.
Build a registration plan
Estimate pathway, government fees, preparation, and review time.
Build a reusable product master
Structure company, product, model, approval, and evidence facts once.
Map dossier reuse and deltas
Compare existing evidence against Tunisia needs.
Build a market-launch workpaper
Connect route, evidence, labels, representatives, and launch dependencies.
Assess a regulatory change
Test a current Agence Nationale du Médicament et des Produits de Santé (ANMPS) update against one product and its evidence.